Institutional experience with Oncotype DX® DCIS assay in radiation treatment plan of ductal carcinoma in situ (DCIS) of the breast

The Breast ◽  
2017 ◽  
Vol 32 ◽  
pp. S93
Author(s):  
A. Calin ◽  
L. De Ingunza ◽  
M. Cebollero ◽  
M.A. Lozano
2015 ◽  
Vol 28 (9) ◽  
pp. 1167-1173 ◽  
Author(s):  
Adriana Knopfelmacher ◽  
Jana Fox ◽  
Yungtai Lo ◽  
Nella Shapiro ◽  
Susan Fineberg

2019 ◽  
Vol 2019 ◽  
Author(s):  
Cosette A. DeChant ◽  
Samantha M. Thomas ◽  
Laura H. Rosenberger ◽  
Oluwadamilola M. Fayanju ◽  
Rachel A. Greenup ◽  
...  

Cancer ◽  
2013 ◽  
Vol 120 (7) ◽  
pp. 1085-1085 ◽  
Author(s):  
Michael D. Lagios ◽  
Melvin J. Silverstein

2019 ◽  
Vol 21 (1) ◽  
Author(s):  
Haojia Li ◽  
Jon Whitney ◽  
Kaustav Bera ◽  
Hannah Gilmore ◽  
Mangesh A. Thorat ◽  
...  

Abstract Background Oncotype DX (ODx) is a 12-gene assay assessing the recurrence risk (high, intermediate, and low) of ductal carcinoma in situ (pre-invasive breast cancer), which guides clinicians regarding prescription of radiotherapy. However, ODx is expensive, time-consuming, and tissue-destructive. In addition, the actual prognostic meaning for the intermediate ODx risk category remains unclear. Methods In this work, we evaluated the ability of quantitative nuclear histomorphometric features extracted from hematoxylin and eosin-stained slide images of 62 ductal carcinoma in situ (DCIS) patients to distinguish between the corresponding ODx risk categories. The prognostic value of the identified image signature was further evaluated on an independent validation set of 30 DCIS patients in its ability to distinguish those DCIS patients who progressed to invasive carcinoma versus those who did not. Following nuclear segmentation and feature extraction, feature ranking strategies were employed to identify the most discriminating features between individual ODx risk categories. The selected features were then combined with machine learning classifiers to establish models to predict ODx risk categories. The model performance was evaluated using the average area under the receiver operating characteristic curve (AUC) using cross validation. In addition, an unsupervised clustering approach was also implemented to evaluate the ability of nuclear histomorphometric features to discriminate between the ODx risk categories. Results Features relating to spatial distribution, orientation disorder, and texture of nuclei were identified as most discriminating between the high ODx and the intermediate, low ODx risk categories. Additionally, the AUC of the most discriminating set of features for the different classification tasks was as follows: (1) high vs low ODx (0.68), (2) high vs. intermediate ODx (0.67), (3) intermediate vs. low ODx (0.57), (4) high and intermediate vs. low ODx (0.63), (5) high vs. low and intermediate ODx (0.66). Additionally, the unsupervised clustering resulted in intermediate ODx risk category patients being co-clustered with low ODx patients compared to high ODx. Conclusion Our results appear to suggest that nuclear histomorphometric features can distinguish high from low and intermediate ODx risk category patients. Additionally, our findings suggest that histomorphometric features for intermediate ODx were more similar to low ODx compared to high ODx risk category.


2015 ◽  
Vol 33 (28_suppl) ◽  
pp. 56-56 ◽  
Author(s):  
Kinzie Matlock ◽  
Jillian M. Lloyd ◽  
W. Bradford Carter ◽  
Edina Grujic ◽  
Thomas G. Frazier

56 Background: Ductal Carcinoma in situ (DCIS) has a wide spectrum of bioagressiveness. Three models used to assess recurrence risk (RR) of DCIS include: the Van-Nuys Prognostic Index (VN), Memorial Sloan Kettering Breast Cancer Nomogram (MN) and Oncotype Dx DCIS Score (OD; Genomic Health, Redwood City, CA). The aim of our study was to evaluate the concordance between these RR models. Methods: An IRB-approved retrospective chart review was performed on 37 consecutive patients at our institution with DCIS from 12/2011-4/2015 who underwent breast conservation surgery and in whom an OD was obtained. The OD and ‘any recurrent event at 10-years’ scores were used to stratify patients into low risk (LR; OD DCIS score <39/<17%), intermediate risk (IR; 39-54/17-24%) and high risk (HR; >54/>24%), as outlined in the original OD study. The ‘10-year RR’ scores from MN were stratified using the same percentile breakdown as OD. The VN were stratified into LR (4-6), IR (7-9) and HR (>9) groups based on the updated VN study’s guideline. Pathologic slides were re-reviewed by one pathologist blinded to OD score to determine size and margin width based on the protocol outlined in the original VN paper. The three scores for each patient were compared. Results: Eleven patients (29.7%) had concordance between all three scores and all were LR. In 10.8% of patients, there was no concordance between the three scores. The concordance between the OD and VN, OD and MN, and VN and MN was 64.9%, 48.6% and 35.1%, respectively. Conclusions: In evaluating RR, determining LR may have the greatest implication since this group may be the least likely to benefit from adjuvant radiotherapy. Concordance between all three models was seen only in LR patients. All patients who were LR by VN were also LR by OD and MN. Determining a VN initially may help guide additional testing. The added value of OD may be primarily in patients who are not LR by VN. The MN seems to be of limited value in this study. Larger studies assessing these relationships and their outcomes in predicting potential RR in DCIS are warranted.


2020 ◽  
Vol 27 (1) ◽  
pp. E202017
Author(s):  
Ankit Prabhakar ◽  
Dawood Iqbal Wani ◽  
Shivani Sharma ◽  
Sajjad Ahmad Dar ◽  
Shaafiya Ashraf

Breast carcinoma is a heterogeneous group of tumors with a wide spectrum of clinical presentations, lesion characterization and diagnostic evaluation. Ductal carcinoma in situ accounts for 15%-20% of breast carcinomas detected in screened populations. Ductal carcinoma in situ has a variable appearance on mammography. The use of mammography has become as a very helpful tool for the early detection of larger number of patients with ductal carcinoma in situ and, thus, offering timely surgery and the need for the appropriate radiation treatment to patients. This study was undertaken as a hospital-based retrospective study to evaluate the varied spectrum of mammographic findings in 57 women with histopathological diagnosis of ductal carcinoma in situ. The spectrum of mammographic findings of ductal carcinoma in situ was found to vary widely. A thorough and vigilant inspection of a mammogram is necessary for all the patients to avoid the possibility of missing early diagnosis of this entity, since the findings are very subtle. Most cases show microcalcifications on mammograms and their early detection can help in early diagnosis, thereby offering conservative surgical approach to a patient. Microcalcifications can be present isolated or in association with a mass. These are mostly clustered in distribution followed by regional, segmental and ductal pattern of distribution. The morphology of microcalcifications is mostly amorphous, followed by pleiomorphic and fine heterogenous types. Hence, the mammogram must be interpreted with strict vigilance and proper attention to all aspects for early and correct diagnosis of ductal carcinoma in situ to help in proper guidance of its treatment.


Rare Tumors ◽  
2012 ◽  
Vol 4 (4) ◽  
pp. 169-171 ◽  
Author(s):  
Takanobu Sato ◽  
Akira Iwasaki ◽  
Takeo Iwama ◽  
Shigeo Kawai ◽  
Tsuyoshi Nakagawa ◽  
...  

We report a very rare case of extensive ductal carcinoma in situ (DCIS) of the breast with secretory features in a 30-year old Japanese woman. The patient presented with a nodule in the lower inner quadrant of the left breast measuring approximately 2–3 cm, accompanied by an irregular tumor shadow with segmental microcalcification on mammography. These findings suggested malignancy, and excisional biopsy was performed following core needle biopsy. Pathological diagnosis was that of DCIS with secretory features. A treatment plan of simple mastectomy and sentinel lymph node biopsy was chosen. Most previous reports have only described invasive secretory carcinoma of the breast. We have only been able to find 2 case reports of non-invasive secretory lesion in the English literature to date. Because the characteristics of this lesion are not widely known, we thought it important to share our findings.


Sign in / Sign up

Export Citation Format

Share Document